Quick Answer
Xtant Medical Holdings, Inc. reported Stockholders Equity of $50.95 million for the year ending 2025.
- Xtant Medical Holdings, Inc. showed an increase of +18.6% in Stockholders Equity from 2024 to 2025.
- This data is from Xtant Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $2.66 million | Q2 2013: $3.44 million | Q3 2013: -$636.0 thousand | Q1 2014: -$6.57 million | Q2 2014: -$7.96 million | Q3 2014: -$4.46 million | Q1 2015: -$10.47 million | Q2 2015: -$11.85 million | Q3 2015: -$2.83 million | Q1 2016: $3.36 million | Q2 2016: -$496.3 thousand | Q3 2016: -$5.10 million | Q1 2017: -$11.67 million | Q2 2017: -$21.29 million | Q3 2017: -$30.23 million | Q1 2018: $15.61 million | Q2 2018: $10.61 million | Q3 2018: $12.66 million | Q1 2019: -$39.18 million | Q2 2019: -$41.08 million | Q3 2019: -$42.86 million | Q1 2020: -$46.48 million | Q2 2020: -$46.86 million | Q3 2020: $47.98 million | Q1 2021: $33.37 million | Q2 2021: $33.88 million | Q3 2021: $32.64 million | Q1 2022: $29.28 million | Q2 2022: $28.14 million | Q3 2022: $32.77 million | Q1 2023: $32.71 million | Q2 2023: $30.96 million | Q3 2023: $54.68 million | Q1 2024: $47.68 million | Q2 2024: $45.01 million | Q3 2024: $45.73 million | Q1 2025: $43.88 million | Q2 2025: $48.50 million | Q3 2025: $50.38 million.
- Over the full 17 years of available data (2009 to 2025), Xtant Medical Holdings, Inc.'s Stockholders Equity has grown by 987.6%.
- Historical annual values: Fiscal year 2025: $50.95 million | Fiscal year 2024: $42.96 million | Fiscal year 2023: $51.35 million | Fiscal year 2022: $34.17 million | Fiscal year 2021: $30.88 million | Fiscal year 2020: $14.51 million | Fiscal year 2019: -$44.21 million | Fiscal year 2018: -$43.77 million | Fiscal year 2017: -$58.70 million | Fiscal year 2016: -$7.07 million | Fiscal year 2015: $8.88 million | Fiscal year 2014: -$7.77 million | Fiscal year 2013: -$3.84 million | Fiscal year 2012: $4.23 million | Fiscal year 2011: $5.50 million | Fiscal year 2010: -$619.2 thousand | Fiscal year 2009: $4.68 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: